Condition
    Preliminary
    Effectiveness 1/5

    Magnesium for TMJ Disorder

    A low-risk adjunct with mechanistic logic and no direct clinical evidence in jaw disorders.

    Overview

    A low-risk adjunct with mechanistic logic and no direct clinical evidence in jaw disorders.

    Verdict

    Insufficient evidence

    Plausible for masticatory muscle tension and sleep quality, but no trial has tested it in temporomandibular disorder.

    How It Works

    Magnesium antagonises calcium at the neuromuscular junction and blocks NMDA receptors involved in central pain sensitisation. Lower magnesium increases neuromuscular excitability, which is theoretically relevant to sustained masticatory muscle contraction and clenching-related pain.

    Dosing & Protocol

    Typical dose

    Recommended dose
    200-400 mg daily of elemental magnesium as glycinate, taken in the evening
    Expected timeframe
    4-8 weeks for any perceptible change

    Protocol

    form
    Not applicable
    duration
    Not applicable
    co factor
    Evidence is insufficient: no controlled trial has tested oral magnesium in temporomandibular disorder. The rationale is extrapolated from neuromuscular and NMDA effects. Occlusal splint therapy, jaw exercises and stress management are the interventions with evidence.
    titration
    Not applicable
    starting dose
    Not applicable as a treatment

    Evidence

    What the studies say

    No randomised trial has evaluated magnesium in temporomandibular disorders. The supporting evidence is entirely indirect and comes from three separate literatures: intravenous magnesium reduces postoperative pain and opioid requirements, supporting the NMDA mechanism in humans; small trials suggest magnesium improves sleep quality in older adults with insomnia, and poor sleep is one of the stronger predictors of TMD symptom persistence; and magnesium has modest evidence in migraine prophylaxis, a condition that frequently coexists with TMD. Against this, oral magnesium raises central nervous system concentrations poorly, and trials of oral magnesium for muscle cramps in older adults were negative. It is inexpensive and safe at standard doses, so a trial period is defensible, but it should sit alongside the interventions with actual evidence — clenching awareness, jaw rest during flares, graded exercises and stress and sleep management.

    No studies are yet linked to both Magnesium and TMJ Disorder.

    Safety

    Caveats

    Doses above 400 mg commonly cause diarrhoea. Accumulates dangerously in kidney impairment. Separate from tetracycline and quinolone antibiotics and bisphosphonates by several hours.

    Less likely to help if

    People whose pain arises from disc displacement or degenerative joint change rather than muscle tension.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.